PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Bannon’s War Room | Evening Edition | Recorded March 15, 2021 | Chaos Under Heaven … China’s Rise is Threat to World (w/ Josh Rogin) | Video: 48 Minutes 59 Seconds

Show Me

“Put down your pen, put down your notebook and listen,” Yasmin said. | If Only We Heeded This Advice Regardless Of Any Side Of An Issue We Take

Show Me

Meghan Markle’s claims during Oprah interview debunked by 2014 blog post

Show Me

Ireland Suspends AstraZeneca Vaccine Amid Blood Clot Reports

Show Me

The Fascistic Drive for Equality

Show Me

Tulsi Gabbard Draws Comparison Between Cancel Culture and ISIS, Al Qaeda

Show Me

White House Won’t Tell Officials How Many Illegal Immigrants Entering Texas Have COVID-19: Gov. Abbott

Show Me

Texas Judge Says Austin Can Continue to Enforce Mask Mandate for at Least Another 2 Weeks

Show Me

Pfizer Vaccine 94 Percent Effective Against Asymptomatic Transmission of CCP Virus: Israeli Data

Show Me

Virus Tolls Similar Despite Governors’ Contrasting Actions

Show Me

Kate Garraway describes husband Derek Draper’s coronavirus battle as ‘horror story’

Show Me

Ex-White House COVID adviser Deborah Birx has new private-sector job

Show Me

Quarantine Hotel Worker in NSW Tests Positive for COVID-19

Show Me

12 shot, two fatally, at overnight party at Park Manor business

Show Me

Riots, Violence Erupt in West Coast Cities on Breonna Taylor Anniversary

Show Me

They’re Back . . . “There was nothing peaceful about the protest. It looked like Black Lives Matter,” one employee told The Post.

Show Me

Cuomo Should ‘Stick to His Guns’: Alan Dershowitz

Show Me

With Biden In Office, ISIS Is Back In Full Swing

Show Me

Video: Remembering the ‘Boat People’ of Vietnam, Who Escaped Communism for America

Show Me

Dr. Fauci Advises Stephen Colbert Not To “Hit The Clubs” Even After Getting Vaccinated

Show Me

These Covid Vaccines Are Now in the U.S. Others May Be Coming.

Show Me

Rudy Giuliani to Keep Honorary Degree After New York College Votes Against Rescinding It

Show Me

Schumer: Andrew Cuomo should resign amid ‘awful crisis’ in New York

Show Me

Amazon says it won’t list books it claims classify transgenderism as a mental illness

Show Me

Netflix rolls out feature to crack down on ‘password-sharing’

Show Me

Why many of those struck by Long Covid may really be suffering from glandular fever

Show Me

Marvelous Marvin Hagler, Middleweight Champion of the 1980s, Dies at 66

Show Me

H.R. 1 Election Reforms Make Problems of 2020 Worse: Fmr FEC Commissioner

Show Me

Illegal immigrant students in Virginia to be eligible for student financial aid

Show Me

Cynthia Nixon supporters remind voters ‘what could have been’ amid Cuomo’s scandals

Show Me

Alabama GOP to Present Framed Resolution to Trump as ‘One of the Greatest and Most Effective’ Presidents

Show Me

The Nation Speaks (March 13) | White House Gender Policy Council Called Sexist, Racist, Anti-Unity

Show Me

Gov. Newsom admits making mistakes in handling of COVID-19 pandemic

Show Me

12 Prominent Scientists and Doctors to EU Regulators: Address ‘Urgent’ Safety Concerns or Halt COVID Vaccines

Show Me

Cuomo’s staffers have stopped going to work and believe he should resign

Show Me

Bannon’s War Room | Saturday Edition Hour 1| Recorded March 13, 2021 | Video: 48 Minutes 50 Seconds

Show Me

Bannon’s War Room | Saturday Edition Hour 2 | Recorded March 13, 2021 | Video: 48 Minutes 47 Seconds

Show Me

Todd Bensman On the Steve Gruber TV Show Discussing the Biden Border Crisis

Show Me

Abuse and Power | Andrew Cuomo’s governorship has been defined by cruelty that disguised chronic mismanagement. Why was that celebrated for so long?

Show Me

Schumer, Gillibrand Say Cuomo Should Resign

Show Me